Abstract:Previous studies have demonstrated that the growth of tumor cells may be inhibited by antisense oligonucleotides (ASODNs) targeted against human telomerase (hTR) or human telomerase reverse transcriptase (hTERT), resulting in antitumor activity in a wide variety of tumors. However, few studies have investigated the effect of hTERT gene-targeted ASODNs on telomerase activity and cell proliferation in human esophageal cancer. In the present study, an MTT assay was used to determine the growth inhibition rate of Eca-109 cells treated with a hTERT-targeted phosphorothioate-ASODN (PS-ASODN). An inverted microscope was used to observe the morphologic changes of the cells following treatment with 5 μM PS-ASODN for 10 days. Telomerase activity was detected using the silver staining semi-quantitative telomeric repeat amplification protocol (TRAP) assay. Following treatment with the PS-ASODN (1-5 μmol/l), the proliferation of the Eca-109 cells was inhibited. The differences in inhibition rate between the PS-ASODN and blank control groups were statistically significant (P<0.05) when the concentration of the PS-ASODN was ≥2 μmol/l, whereas no statistically significant difference was identified between the non-specific-ASODN and blank control groups. The inhibition rate increased gradually as the concentration of the PS-ASODN increased and with time, suggesting that the PS-ASODN inhibited the growth of Eca-109 cells in a concentration-dependent, time-dependent and sequence-specific manner. The growth rate of the cells incubated with the PS-ASODN was reduced compared with that of the control cells. Cells treated with the PS-ASODN became round, suspended and reduced in size. The PS-ASODN was also found to inhibit telomerase activity. The ability of the PS-ASODN to inhibit the telomerase activity and cell proliferation of the Eca-109 cell line suggests that ASODNs have the potential to be novel therapeutic agents for the treatment of esophageal cancer.

Enhanced Growth Inhibition Effect of Antisense Oligonucleotides Mediated by Cationic Liposomes on HeLa Cells

In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.

Telomerase-targeting antisense oligonucleotides carried by polycation liposomes enhance the growth inhibition effect on tumor cells.

Effect Of Antisense Oligodeoxynucleotides Glucose Transporter-1 On Enhancement Of Radiosensitivity Of Laryngeal Carcinoma

EFFECTS OF DIFFERENT CONCENTRATIONS OF ANTISENSE OLIGODEOXYNUCLEOTIDES(ASODN) ON HUMAN PANCREATIC CANCER CELL LINE PaTu8988s

Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells

[Telomerase RNA Antisense Oligonucleotides Inhibit Growth of Human Choriocarcinoma Xenograft in Nude Mice].

Anti-liver Cancer Activity of TNF-related Apoptosis-Inducing Ligand Gene and Its Bystander Effects.

Inhibition of Telomerase Activity and Induction of Cell Apoptosis in Cutaneous T-cell Lymphoma Cell Line by Human Telomerase Reverse Transcriptase Gene Antisense Oligodeoxynucleotide

Antisense Oligonucleotides Targeting Human Telomerase Mrna Increases the Radiosensitivity of Nasopharyngeal Carcinoma Cells

Inhibitory Effect of Antisense Oligodeoxynucleotides Against Htert on Nude Mice Transplantation Tumor of Human Tongue Tca8113 Cancer Cell

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Effects of antisense phosphorothioate oligodeoxynucletides targeted againt bcl-2 mRNA on telomerase activity of gastric cancer SGC-7901 cell

Antisense Htert Inhibits Thyroid Cancer Cell Growth.

Delivering Antisense Telomerase RNA by a Hybrid Adenovirus/ Adeno-Associated Virus Significantly Suppresses the Malignant Phenotype and Enhances Cell Apoptosis of Human Breast Cancer Cells

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Structural Optimization and Additional Targets Identification of Antisense Oligonucleotide G3139 Encapsulated in a Neutral Cytidinyl-Lipid Combined with a Cationic Lipid in Vitro and in Vivo

Modified ASO Conjugates Encapsulated with Cytidinyl/cationic Lipids Exhibit More Potent and Longer-Lasting Anti-Hcc Effects

[Antisense Oligodeoxynucleotides of Human Telomerase Reverse Transcriptase Inhibit Endometrial Carcinoma Cell HEC-1A Proliferation].

Antitumor Efficacy of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide in Pancreatic Cancer Cells.

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.